SNDX
Syndax Pharmaceuticals Inc
NASDAQ: SNDX · HEALTHCARE · BIOTECHNOLOGY
$20.65
+2.74% today
Updated 2026-05-06
Market cap
$1.69B
P/E ratio
—
P/S ratio
7.79x
EPS (TTM)
$-2.79
Dividend yield
—
52W range
$9 – $26
Volume
1.6M
Syndax Pharmaceuticals Inc (SNDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $627000.00 | $1.22M | $2.11M | $1.52M | $1.52M | $1.52M | $139.71M | $126.58M | $0.00 | $23.68M | $172.35M |
| Revenue growth (YoY) | — | — | — | — | — | +94.6% | +72.8% | -28.0% | +0.0% | +0.0% | +9109.6% | -9.4% | -100.0% | — | +627.8% |
| Cost of revenue | $51000.00 | — | — | $0.00 | $21.12M | $41.70M | $63.99M | $0.00 | — | — | $456000.00 | $454000.00 | $12000.00 | $826000.00 | $6.97M |
| Gross profit | $-51000.00 | — | — | $0.00 | $627000.00 | $1.22M | $2.11M | $1.52M | $1.52M | $1.52M | $139.71M | $-454000.00 | $-12000.00 | $22.85M | $165.38M |
| Gross margin | — | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -0.4% | — | 96.5% | 96.0% |
| R&D | $6.09M | $5.24M | $3.21M | $10.18M | $9.55M | $31.66M | $48.20M | $60.11M | $42.99M | $50.44M | $88.25M | $118.50M | $163.03M | $241.65M | $258.78M |
| SG&A | — | $3.49M | $5.36M | $11.16M | $11.59M | $13.32M | $15.86M | $17.29M | $16.06M | $22.50M | $25.24M | $33.26M | $66.92M | $120.88M | $179.68M |
| Operating income | $-9.62M | $-8.73M | $-8.57M | $-21.33M | $-20.51M | $-43.77M | $-61.95M | $-75.88M | $-57.54M | $-71.42M | $26.22M | $-151.76M | $-229.95M | $-339.67M | $-273.08M |
| Operating margin | — | — | — | — | -3271.6% | -3587.4% | -2939.0% | -5001.7% | -3792.9% | -4708.2% | 18.8% | -119.9% | — | -1434.4% | -158.4% |
| EBITDA | $-11.05M | $-5.26M | $-8.56M | $-21.32M | $-20.49M | $-43.68M | $-61.88M | $-75.80M | $-57.45M | $-71.33M | $26.26M | $-151.72M | $-209.14M | $-313.82M | $-251.63M |
| EBITDA margin | — | — | — | — | -3268.3% | -3580.1% | -2935.4% | -4996.6% | -3786.9% | -4702.3% | 18.8% | -119.9% | — | -1325.3% | -146.0% |
| EBIT | $-11.10M | $-5.29M | $-8.57M | $-21.33M | $-20.51M | $-43.77M | $-61.95M | $-75.88M | $-57.54M | $-71.42M | $26.22M | $-151.76M | $-209.15M | $-313.83M | $-251.64M |
| Interest expense | $1.99M | $0.00 | $0.00 | $0.00 | $1.57M | $956000.00 | $1.42M | $1.94M | $1.57M | $2.36M | $1.90M | $3.14M | $208000.00 | $4.93M | $33.78M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-13.09M | $-9.96M | $-14.17M | $-19.83M | $-24.12M | $-44.47M | $-60.80M | $-73.96M | $-55.95M | $-73.07M | $24.93M | $-143.75M | $-209.36M | $-318.76M | $-285.42M |
| Net income growth (YoY) | — | +23.9% | -42.2% | -39.9% | -21.6% | -84.4% | -36.7% | -21.6% | +24.3% | -30.6% | +134.1% | -676.7% | -45.6% | -52.3% | +10.5% |
| Profit margin | — | — | — | — | -3846.7% | -3645.2% | -2884.3% | -4875.5% | -3688.5% | -4816.7% | 17.8% | -113.6% | — | -1346.1% | -165.6% |